TSLA

Up 3.8% and back above the 20-day (331) with the week +7.2%, but the 50/200-day (373/407) still cap the tape, YTD -25.7% on a 316x P/E and the Street sees only 10.5% upside. A bounce, not a trend — sidelines.

Slipped 1.59% on light volume with every moving average overhead (the 200-day sits way up at 407), down 28.5% YTD at a vertiginous 304x P/E. Talk of divesting the China business adds uncertainty and the 375.5 average target leaves just 14.7% upside—staying flat.

Up 0.58% in a token bounce but still under every moving average with RSI at a soft 43.5, only 11.9% above its 52-week low, and 309x earnings against 11.8% revenue growth; a 1.72 rating across 49 analysts is the weakest in today's coverage — remaining on the sidelines.

A complete bearish stack, RSI at 42.5 that is not oversold enough, and volume shrunk to 0.69x leave no technical basis for a long; shorting 10.1% off the 52-week low means entering at the worst possible odds. A 307x multiple sitting 33.7% below its high says it is neither cheap nor strong — a name to skip rather than trade.

Up 2.83% in a bounce with RSI still weak at 41.4, below the 50-day at $380.44 and 200-day at $408.80, at 305x against EPS down 37.7%; sidelines.

Down 0.63% with RSI weak at 36.9, still below the 50-day at $382.68 and 200-day at $409.39, at 296.9x against EPS down 37.7%; sidelines.

RSI 38 soft and 22% below the SMA200, with weak deliveries and Musk's split focus — watchlist observation, no direction yet; await stabilization.

Up 1.64%, clearly trailing the Nasdaq's 2.59%, still below all three moving averages with RSI weak at 39.2, and 304x earnings against EPS down 37.7%; sidelines.

Maintaining sidelines. A 3.49% low-volume bounce on a day the Nasdaq gained 2.1% shows nothing in relative strength. A 299x multiple against -37.7% earnings growth means any 'oversold' discussion is happening on the wrong axis — multiple compression is the main story, and RSI at 36.8 isn't even oversold. The China divestiture report adds a new strategic variable that cannot be priced. Wait for the reaction at $297.38.

Holding last period's neutral (staying flat). RSI7 at 15.4 does raise the odds of a technical bounce, but a fully bearish moving-average structure plus deteriorating fundamentals (1.4% operating margin, negative FCF) leave any rally without fundamental support — going long here is a counter-trend bet with poor odds. Equally, a 285x multiple alongside a 32.8% YTD decline means multiple compression could still have room, yet with price hugging the 52-week low and tonight's Fed decision in play, shorting here is chasing weakness at the lows with unattractive risk/reward. Neither side has an edge, so staying flat is the only honest call — wait for $297.82 to break or for a high-volume reversal to set direction.

Day-after odds on a $19-ATR breakdown candle are poor, with the $297.8 52-week low one step away: hold it and you have double-bottom material, lose it and there's air below. Earnings damage needs 3-5 sessions to digest — sidelines is a position

An earnings night with a ±6% straddle offers no disciplined entry; go long only on a post-print volume reclaim of $395, step aside below $360 — trade confirmation, not prediction

The first of the twin triggers set on 7/17 (intraday $390 break / Monday close under $395) fired on Friday, and discipline says exit before earnings. The 7/2 long closes at a loss — tuition for the second confirmation that a full position into earnings means outsourcing discipline to the gap

This is the position's final holding statement: it must reclaim the 20-day ($399) on its own, or Monday's close ends the trade. After IBM, 'wait for the earnings flip' is no longer a legal strategy in this ledger.

The original discipline stands, but event risk got a heavier weight: with the stop in its face and earnings imminent, choosing 'trim first' over 'wait for the stop' is exactly what this week's tuition paid for.

The stop is 1.2% away: if it triggers, walk — earnings are the next train. If it holds, the trend is intact and the position rides unchanged into 7/22. The delivery beat is priced; earnings bet the margin, and that's not this position's wager.

Up 0.3%, secure above the 20-day awaiting 7/22 earnings; stop stays $390, no moves before the print

Holding: the 20-day reclaim defused the breakdown, but pre-earnings upside is ridden with a frozen position. The $390 hard stop stands — an unexplained break before the print means the market knows something early.

Holding: delivery and robotaxi catalysts are landing, but consensus targets hugging spot mean upside requires estimate revisions. The $390 hard stop is body armor; failure to reclaim the 20-day ($399) pre-earnings would flag fading momentum.

Keep the long but downgrade to lean bullish: the failed 200-day reclaim weakens the trend signal, with the 20-day ($399.8) and the $390 stop as twin defenses. Hold them and there's room to repair into earnings; below $390, exit unconditionally — don't gamble the print.

Reclaimed the 200-day with a moving-average alignment forming plus momentum — turning bullish short-term. A held retest of $405–415 confirms; target the $450 supply. A break of $390 (below the 200-day) fails the reclaim — exit. Don't be full-size into the 7/22 print.

The $399–419 moving-average band overhead needs time to clear; $370 is the June platform below. With IV elevated pre-earnings, directional bets are worse than premium-selling. The delivery catalyst is spent — 7/22 margins are the real watershed.

Pre-print it's a coin flip, and the +12% week already priced in optimism — an in-line number could sell off. After the data: long above $406 (50-day), out below $400.